The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Fibrinogen (factor I) is a glycoprotein in vertebrates that helps in the formation of blood clots. Human Fibrinogen is used as a medicine for blood disease. Human Fibrinogen is a preparation of coagulation factors prepared from pooled plasma. Currently, only RiaSTAP (CSL Behring) is licensed in a number of countries for multiple indications including treating acute bleeding episodes with Hypofibrinogenemia. Other manufacturer’s products are justly used in local region or countries.
The global Human Fibrinogen market was valued at US$ 795.8 million in 2023 and is anticipated to reach US$ 2207 million by 2030, witnessing a CAGR of 15.5% during the forecast period 2024-2030.
Global Human Fibrinogen key players include CSL Behring, LFB Group, Shanghai RAAS Blood Products, Jiangxi Boya Bio-Pharmaceutical, GREEN CROSS, etc. Global top five manufacturers hold a share about 90%. Asia-Pacific is the largest consumption market, with a share about 60%, followed by Americas and Europe, total have a share over 30 percent. In terms of product, Human Fibrinogen Concentrate is the largest segment, with a share over 99%. And in terms of application, the largest application is Surgical Procedures.
This report aims to provide a comprehensive presentation of the global market for Human Fibrinogen, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Fibrinogen.
Report Scope
The Human Fibrinogen market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Fibrinogen market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Fibrinogen manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
- CSL Behring
- LFB Group
- Shanghai RAAS Blood Products
- Jiangxi Boya Bio-Pharmaceutical
- Hualan Biological Engineering
- Harbin Pacific Biopharmaceutical
- GREEN CROSS
- Shanghai XinXing Medical
- Octapharma
Segment by Type
- Human Fibrinogen Concentrate
- Animal Fibrinogen Concentrate
Segment by Application
- Congenital Fibrinogen Deficiency
- Surgical Procedures
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Fibrinogen manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Fibrinogen in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Human Fibrinogen Market Overview
1.1 Product Overview and Scope of Human Fibrinogen
1.2 Human Fibrinogen Segment by Type
1.2.1 Global Human Fibrinogen Market Value Comparison by Type (2024-2030)
1.2.2 Human Fibrinogen Concentrate
1.2.3 Animal Fibrinogen Concentrate
1.3 Human Fibrinogen Segment by Application
1.3.1 Global Human Fibrinogen Market Value by Application: (2024-2030)
1.3.2 Congenital Fibrinogen Deficiency
1.3.3 Surgical Procedures
1.4 Global Human Fibrinogen Market Size Estimates and Forecasts
1.4.1 Global Human Fibrinogen Revenue 2019-2030
1.4.2 Global Human Fibrinogen Sales 2019-2030
1.4.3 Global Human Fibrinogen Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Human Fibrinogen Market Competition by Manufacturers
2.1 Global Human Fibrinogen Sales Market Share by Manufacturers (2019-2024)
2.2 Global Human Fibrinogen Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Human Fibrinogen Average Price by Manufacturers (2019-2024)
2.4 Global Human Fibrinogen Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human Fibrinogen, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Fibrinogen, Product Type & Application
2.7 Human Fibrinogen Market Competitive Situation and Trends
2.7.1 Human Fibrinogen Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Human Fibrinogen Players Market Share by Revenue
2.7.3 Global Human Fibrinogen Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Human Fibrinogen Retrospective Market Scenario by Region
3.1 Global Human Fibrinogen Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Human Fibrinogen Global Human Fibrinogen Sales by Region: 2019-2030
3.2.1 Global Human Fibrinogen Sales by Region: 2019-2024
3.2.2 Global Human Fibrinogen Sales by Region: 2025-2030
3.3 Global Human Fibrinogen Global Human Fibrinogen Revenue by Region: 2019-2030
3.3.1 Global Human Fibrinogen Revenue by Region: 2019-2024
3.3.2 Global Human Fibrinogen Revenue by Region: 2025-2030
3.4 North America Human Fibrinogen Market Facts & Figures by Country
3.4.1 North America Human Fibrinogen Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Human Fibrinogen Sales by Country (2019-2030)
3.4.3 North America Human Fibrinogen Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Human Fibrinogen Market Facts & Figures by Country
3.5.1 Europe Human Fibrinogen Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Human Fibrinogen Sales by Country (2019-2030)
3.5.3 Europe Human Fibrinogen Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Fibrinogen Market Facts & Figures by Country
3.6.1 Asia Pacific Human Fibrinogen Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Human Fibrinogen Sales by Country (2019-2030)
3.6.3 Asia Pacific Human Fibrinogen Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Human Fibrinogen Market Facts & Figures by Country
3.7.1 Latin America Human Fibrinogen Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Human Fibrinogen Sales by Country (2019-2030)
3.7.3 Latin America Human Fibrinogen Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Fibrinogen Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Fibrinogen Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Human Fibrinogen Sales by Country (2019-2030)
3.8.3 Middle East and Africa Human Fibrinogen Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Human Fibrinogen Sales by Type (2019-2030)
4.1.1 Global Human Fibrinogen Sales by Type (2019-2024)
4.1.2 Global Human Fibrinogen Sales by Type (2025-2030)
4.1.3 Global Human Fibrinogen Sales Market Share by Type (2019-2030)
4.2 Global Human Fibrinogen Revenue by Type (2019-2030)
4.2.1 Global Human Fibrinogen Revenue by Type (2019-2024)
4.2.2 Global Human Fibrinogen Revenue by Type (2025-2030)
4.2.3 Global Human Fibrinogen Revenue Market Share by Type (2019-2030)
4.3 Global Human Fibrinogen Price by Type (2019-2030)
5 Segment by Application
5.1 Global Human Fibrinogen Sales by Application (2019-2030)
5.1.1 Global Human Fibrinogen Sales by Application (2019-2024)
5.1.2 Global Human Fibrinogen Sales by Application (2025-2030)
5.1.3 Global Human Fibrinogen Sales Market Share by Application (2019-2030)
5.2 Global Human Fibrinogen Revenue by Application (2019-2030)
5.2.1 Global Human Fibrinogen Revenue by Application (2019-2024)
5.2.2 Global Human Fibrinogen Revenue by Application (2025-2030)
5.2.3 Global Human Fibrinogen Revenue Market Share by Application (2019-2030)
5.3 Global Human Fibrinogen Price by Application (2019-2030)
6 Key Companies Profiled
6.1 CSL Behring
6.1.1 CSL Behring Corporation Information
6.1.2 CSL Behring Description and Business Overview
6.1.3 CSL Behring Human Fibrinogen Sales, Revenue and Gross Margin (2019-2024)
6.1.4 CSL Behring Human Fibrinogen Product Portfolio
6.1.5 CSL Behring Recent Developments/Updates
6.2 LFB Group
6.2.1 LFB Group Corporation Information
6.2.2 LFB Group Description and Business Overview
6.2.3 LFB Group Human Fibrinogen Sales, Revenue and Gross Margin (2019-2024)
6.2.4 LFB Group Human Fibrinogen Product Portfolio
6.2.5 LFB Group Recent Developments/Updates
6.3 Shanghai RAAS Blood Products
6.3.1 Shanghai RAAS Blood Products Corporation Information
6.3.2 Shanghai RAAS Blood Products Description and Business Overview
6.3.3 Shanghai RAAS Blood Products Human Fibrinogen Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Shanghai RAAS Blood Products Human Fibrinogen Product Portfolio
6.3.5 Shanghai RAAS Blood Products Recent Developments/Updates
6.4 Jiangxi Boya Bio-Pharmaceutical
6.4.1 Jiangxi Boya Bio-Pharmaceutical Corporation Information
6.4.2 Jiangxi Boya Bio-Pharmaceutical Description and Business Overview
6.4.3 Jiangxi Boya Bio-Pharmaceutical Human Fibrinogen Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Jiangxi Boya Bio-Pharmaceutical Human Fibrinogen Product Portfolio
6.4.5 Jiangxi Boya Bio-Pharmaceutical Recent Developments/Updates
6.5 Hualan Biological Engineering
6.5.1 Hualan Biological Engineering Corporation Information
6.5.2 Hualan Biological Engineering Description and Business Overview
6.5.3 Hualan Biological Engineering Human Fibrinogen Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Hualan Biological Engineering Human Fibrinogen Product Portfolio
6.5.5 Hualan Biological Engineering Recent Developments/Updates
6.6 Harbin Pacific Biopharmaceutical
6.6.1 Harbin Pacific Biopharmaceutical Corporation Information
6.6.2 Harbin Pacific Biopharmaceutical Description and Business Overview
6.6.3 Harbin Pacific Biopharmaceutical Human Fibrinogen Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Harbin Pacific Biopharmaceutical Human Fibrinogen Product Portfolio
6.6.5 Harbin Pacific Biopharmaceutical Recent Developments/Updates
6.7 GREEN CROSS
6.6.1 GREEN CROSS Corporation Information
6.6.2 GREEN CROSS Description and Business Overview
6.6.3 GREEN CROSS Human Fibrinogen Sales, Revenue and Gross Margin (2019-2024)
6.4.4 GREEN CROSS Human Fibrinogen Product Portfolio
6.7.5 GREEN CROSS Recent Developments/Updates
6.8 Shanghai XinXing Medical
6.8.1 Shanghai XinXing Medical Corporation Information
6.8.2 Shanghai XinXing Medical Description and Business Overview
6.8.3 Shanghai XinXing Medical Human Fibrinogen Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Shanghai XinXing Medical Human Fibrinogen Product Portfolio
6.8.5 Shanghai XinXing Medical Recent Developments/Updates
6.9 Octapharma
6.9.1 Octapharma Corporation Information
6.9.2 Octapharma Description and Business Overview
6.9.3 Octapharma Human Fibrinogen Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Octapharma Human Fibrinogen Product Portfolio
6.9.5 Octapharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Fibrinogen Industry Chain Analysis
7.2 Human Fibrinogen Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Fibrinogen Production Mode & Process
7.4 Human Fibrinogen Sales and Marketing
7.4.1 Human Fibrinogen Sales Channels
7.4.2 Human Fibrinogen Distributors
7.5 Human Fibrinogen Customers
8 Human Fibrinogen Market Dynamics
8.1 Human Fibrinogen Industry Trends
8.2 Human Fibrinogen Market Drivers
8.3 Human Fibrinogen Market Challenges
8.4 Human Fibrinogen Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
